About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 661-680 of 690 trials

CompletedA Pharmacokinetic Study of Genistein, a Tyrosine Kinase InhibitorGenistein is a natural product found in soy beans; its consumption has been associated with a low incidence of metastatic prostate cancer.NCT00001696·Bethesda, Maryland RecruitingStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor…NCT06855277·Homewood, Alabama and 105 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAdenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerThis is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with…NCT04381832·Cerritos, California and 18 others

TerminatedDexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and DocetaxelThis pilot trial studies how well dexamethasone and re-treatment with enzalutamide work in treating patients with prostate cancer that has spread to other places in the body…NCT02491411·Baltimore, Maryland

CompletedA Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate CancerThis is the first study of MLN2704 administered to humans.NCT00052000·Baltimore, Maryland and 1 other

CompletedRelationship Between Mitochondrial Dysfunction and Fatique in Cancer Patients Following External Beam Radiation TherapyBackground: \- Fatigue is a very common early and late side effect of cancer treatment, including radiation therapy.NCT01143467·Bethesda, Maryland

Unknown[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and ApplicationPhase 1: The objective of the Phase 1 part of the clinical trial is to verify safety and tolerability (dose-limiting toxicity \[DLT\], maximum tolerated dose \[MTD\]) of a single…NCT05458544·Los Angeles, California and 3 others

RecruitingA Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPhase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, intermediate-risk prostate…NCT07332000·Peoria, Arizona and 6 others

CompletedA Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate CancerThis research is being done to see if an investigational prostate cancer vaccine, called GVAX, can safely be given together with a single intravenous injection of a drug called…NCT01696877·Baltimore, Maryland

UnknownPRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate BiopsyThe purpose of this study is to develop and validate a blood-based diagnostic test that will predict prostate biopsy outcome as positive or negative for prostate cancer.NCT00966095·San Bernardino, California and 16 others

CompletedAmifostine to Protect the Rectum During External Beam Radiotherapy for Prostate CancerThis study will evaluate the safety and effectiveness of a drug called amifostine in reducing the bowel side effects of radiation treatment for prostate cancer.NCT00040365·Bethesda, Maryland

RecruitingSurface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate CancerBackground: Men who are treated for prostate cancer often develop urinary leakage (incontinence).NCT06161506·Bethesda, Maryland

CompletedThe Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer DiagnosisSocial comparisons may function as a coping strategy, but their role in coping and quality of life has not been well characterized.NCT01176526·Bethesda, Maryland

TerminatedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerEnthuse M0 is a large phase III clinical trial studying the efficacy of ZD4054 (Zibotentan) in hormone resistant prostate cancer (HRPC).NCT00626548·Tucson, Arizona and 321 others

CompletedRobot-Assisted MRI-Guided Prostate BiopsyProstate biopsies are commonly performed freehanded under transrectal ultrasound guidance (TRUS).NCT02080052·Baltimore, Maryland

CompletedA Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory NeoplasmsThis is a dosage escalation study to estimate the maximum tolerated dose of staurosporine analogue UCN-01.NCT00001444·Bethesda, Maryland

CompletedRE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)Single-arm, single site, open label study of the effects of parenteral testosterone followed by enzalutamide, abiraterone or castration-only therapy in men with metastatic CRPC…NCT02090114·Washington D.C., District of Columbia and 1 other

TerminatedNeoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerThis is a single-center, single arm, open-label phase II study evaluating the safety, anti-tumor effect, and immunogenicity of neoadjuvant Dupixent given prior to radical…NCT03886493·Baltimore, Maryland

RecruitingStudy of ORIC-944 in Patients With Metastatic Prostate CancerThe purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic…NCT05413421·Colorado Springs, Colorado and 26 others

RecruitingSequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionAsymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized…NCT04363164·San Diego, California and 5 others

PreviousPage 34 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma